Clinical trial of the oral form of a new podophyllotoxin derivative, VP-16-213 (NSC-141540), in patients with advanced neoplastic disease.
作者信息
Nissen N I, Hansen H H, Pedersen H, Stroyer I, Dombernowsky P, Hessellund M
出版信息
Cancer Chemother Rep. 1975 Sep-Oct;59(5):1027-9.
PMID:1106845
Abstract
摘要
Zotero 插件